Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blood

Showing results (1221-1230 of 39,482) with videos related to

Pageof 3,949
Sort By:
Blood|December 20, 2018
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with <i>FLT3</i>-ITDRichard F Schlenk, Daniela Weber, Walter Fiedler, et al.
Blood|February 1, 1987
Human erythroleukemia cells adhere to fibronectin: evidence for a Mr 190,000-receptor proteinI Virtanen, J Ylänne, T Vartio
Blood|March 1, 2018
Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-upRobert J Kreitman, Martin S Tallman, Tadeusz Robak, et al.
Blood|December 21, 2013
Factor VIII inhibitor epitopes and an enigmaGary E Gilbert
Blood|December 21, 2013
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusionPavan Bachireddy, Ursula Hainz, Michael Rooney, et al.
Blood|December 25, 2013
Thrombosis: tangled up in NETsKimberly Martinod, Denisa D Wagner
Blood|December 25, 2013
The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesisZachary R Hunter, Lian Xu, Guang Yang, et al.
Blood|December 25, 2013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesElisa Rumi, Daniela Pietra, Virginia Ferretti, et al.
Blood|May 1, 1987
The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitorS L Hersch, T Kunelis, R B Francis
Blood|May 1, 1987
Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemiaC Kelleher, J Miyauchi, G Wong, et al.
Pageof 3,949

Showing results (1221-1230 of 39,482) with videos related to

Sort By:
Pageof 3,949
Blood|December 20, 2018
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with <i>FLT3</i>-ITDRichard F Schlenk, Daniela Weber, Walter Fiedler, et al.
Blood|February 1, 1987
Human erythroleukemia cells adhere to fibronectin: evidence for a Mr 190,000-receptor proteinI Virtanen, J Ylänne, T Vartio
Blood|March 1, 2018
Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-upRobert J Kreitman, Martin S Tallman, Tadeusz Robak, et al.
Blood|December 21, 2013
Factor VIII inhibitor epitopes and an enigmaGary E Gilbert
Blood|December 21, 2013
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusionPavan Bachireddy, Ursula Hainz, Michael Rooney, et al.
Blood|December 25, 2013
Thrombosis: tangled up in NETsKimberly Martinod, Denisa D Wagner
Blood|December 25, 2013
The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesisZachary R Hunter, Lian Xu, Guang Yang, et al.
Blood|December 25, 2013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesElisa Rumi, Daniela Pietra, Virginia Ferretti, et al.
Blood|May 1, 1987
The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitorS L Hersch, T Kunelis, R B Francis
Blood|May 1, 1987
Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemiaC Kelleher, J Miyauchi, G Wong, et al.
Pageof 3,949